There are 2789 resources available
1190TiP - SKYSCRAPER-03: Phase III, open-label randomised study of atezolizumab + tiragolumab vs durvalumab in patients with locally advanced, unresectable, stage III non-small cell lung cancer (NSCLC) who have not progressed after platinum-based concurrent chemoradiation (cCRT)
Presenter: Rafal Dziadziuszko
Session: ePoster Display
1195P - Brigatinib (BRG) vs crizotinib (CRZ) in ALK TKI–naive ALK+ NSCLC: Final results from ALTA-1L
Presenter: Sanjay Popat
Session: ePoster Display
1196P - Pre-existing and acquired mechanisms of resistance to lorlatinib in previously treated patients (pts) with ALK+ advanced non-small cell lung cancer (NSCLC)
Presenter: Ben Solomon
Session: ePoster Display
1127P - Cancer and Age Research Group (CARG) predicting chemotherapy toxicity in elderly patients with cancer
Presenter: Dalila Miraoui
Session: ePoster Display
1128P - Genotypic and phenotypic evaluation of the pharmacokinetics of irinotecan and its relationship with the occurrence of toxicity in the treatment of cancer
Presenter: Jeziel Basso
Session: ePoster Display
1129P - Comparison of predictive value of ASIA criteria and PD-L1 expression in patients taking checkpoint inhibitors in real clinical practice
Presenter: Natalia Zhukova
Session: ePoster Display
1130P - Anchored multiplex PCR-based targeted sequencing for the detection of fusion transcripts in FFPE samples of non-small cell lung cancer patients
Presenter: Audrey Vallée
Session: ePoster Display
1131P - Intraoperative assessment of negative resection margins in breast-conserving surgery using optical coherence elastography
Presenter: Ekaterina Gubarkova
Session: ePoster Display
1132P - In vivo morphological segmentation of tumor by OCT-elastography
Presenter: Anton Plekhanov
Session: ePoster Display
1133P - Whole genome sequencing can classify diagnostically challenging tumors
Presenter: Luuk Schipper
Session: ePoster Display